References in periodicals archive ?
A number of factors affect initiation of LTBI therapy in mobile populations, including provider communication about treatment for LTBI versus active disease, barriers to access LTBI therapy, duration of treatment, financial and medical risk of medications, patient willingness to accept therapy, and provider willingness to prescribe treatment given the risk for loss to follow-up.
Only a select few countries employ some form of mandated LTBI screening (8), and data are scarce on the yield of such programs.
"Most systemic agents used in psoriasis are immunosuppressive and require appropriate screening, monitoring, and prophylaxis when used in [psoriasis] patients with chronic infections, such as hepatitis, HIV and LTBI," the authors concluded.
 Some healthcare systems routinely test their employees using IGRAs, whereas others have continued to use TST for LTBI screening among their employees.
Latent TB infection (LTBI) is characterized by the presence of immune responses to Mycobacterium tuberculosis infection without clinical evidence of active TB. It is estimated that one-third of the human population harbors TB in its latent form, and from this reservoir, active TB will develop in the coming decades.
Much needed at country levels are: a) strong governance and stewardship towards the TB program within the Ministry of Health (i.e., to establish a strong and suitable National TB Program (NTP) with strong NTP central unit to lead the TB elimination strategy); b) manage treatment of LTBI in particular the foreign-born population originating from high prevalence TB countries; (15) c) develop strategies to address other vulnerable groups such as HIV patients and diabetics, and organize a framework for care and control of TB in both groups through integration between the NTP and national HIV/AIDS and diabetes programs; and d) establish ways of monitoring and evaluating the programs so the impact is sustained and maintained.
Identification of patients with LTBI is a challenge because there is no gold standard.
As T-SPOT.TB tests are unable to distinguish between LTBI and active TB, the specificity of the T-SPOT.TB test depends on the prevalence of LTBI.
Although the human immune response is highly effective at controlling the initial infection with Mycobacterium tuberculosis , in some individuals, all viable organisms may not be eliminated, which leads to a latent tuberculosis infection (LTBI).
Dorina et al., "Treatment for LTBI in contacts of MDR-TB patients, Federated States of Micronesia, 2009-2012," The International Journal of Tuberculosis and Lung Disease, vol.
Latent TB infection (LTBI) is a state during which a persistent host immune response to stimulation by Mtb antigens is sustained without evidence of clinically manifested active TB [4, 5].
Acronyms browser ?
Full browser ?
- LTB4 receptor JULF2
- LTB4-R 1
- LTB4-R 2
- LTC4 transporter